This company has been marked as potentially delisted and may not be actively trading. NASDAQ:XRTX XORTX Therapeutics (XRTX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock About XORTX Therapeutics Stock (NASDAQ:XRTX) 30 days 90 days 365 days Advanced Chart Get XORTX Therapeutics alerts:Sign Up Key Stats Today's Range$0.84▼$0.9350-Day Range N/A52-Week Range N/AVolume3.50 million shsAverage Volume210,848 shsMarket Capitalization$3.41 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd. Read More XORTX Therapeutics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreXRTX MarketRank™: XORTX Therapeutics scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for XORTX Therapeutics. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioXORTX Therapeutics has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.08% of the float of XORTX Therapeutics has been sold short.Short Interest Ratio / Days to CoverXORTX Therapeutics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in XORTX Therapeutics has recently decreased by 75.86%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldXORTX Therapeutics does not currently pay a dividend.Dividend GrowthXORTX Therapeutics does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.08% of the float of XORTX Therapeutics has been sold short.Short Interest Ratio / Days to CoverXORTX Therapeutics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in XORTX Therapeutics has recently decreased by 75.86%, indicating that investor sentiment is improving significantly. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for XORTX Therapeutics this week, compared to 0 articles on an average week.Search Interest1 people have searched for XRTX on MarketBeat in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, XORTX Therapeutics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.90% of the stock of XORTX Therapeutics is held by insiders.Percentage Held by InstitutionsOnly 0.23% of the stock of XORTX Therapeutics is held by institutions.Read more about XORTX Therapeutics' insider trading history. Receive XRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for XORTX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address XRTX Stock News HeadlinesXRTX XORTX Therapeutics Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comXORTX Announces USD $925,000 Private PlacementJune 26, 2025 | globenewswire.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. | Porter & Company (Ad)XORTX Therapeutics looks to raise $3M through private placementMay 19, 2025 | msn.comXORTX Announces USD $3 Million OfferingMay 19, 2025 | globenewswire.comXORTX Therapeutics receives Nasdaq notice for non-complianceApril 18, 2025 | msn.comXORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyApril 17, 2025 | globenewswire.comXORTX Therapeutics Inc (XRTX) Gets a Buy from Alliance Global PartnersFebruary 27, 2025 | markets.businessinsider.comSee More Headlines XRTX Stock Analysis - Frequently Asked Questions How were XORTX Therapeutics' earnings last quarter? XORTX Therapeutics Inc. (NASDAQ:XRTX) released its quarterly earnings results on Thursday, May, 15th. The technology company reported ($0.19) EPS for the quarter. When did XORTX Therapeutics' stock split? XORTX Therapeutics's stock reverse split on Friday, November 10th 2023.The 1-9 reverse split was announced on Friday, November 10th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split. What other stocks do shareholders of XORTX Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that XORTX Therapeutics investors own include NVIDIA (NVDA), Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN) and EUDA Health (EUDA). Company Calendar Last Earnings5/15/2025Today7/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryN/A Current SymbolNASDAQ:XRTX CIK1284823 Webwww.xyratex.com Phone+44-23-92496000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($1.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.31 million Net MarginsN/A Pretax MarginN/A Return on Equity-36.38% Return on Assets-24.45% Debt Debt-to-Equity RatioN/A Current Ratio2.78 Quick Ratio2.78 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.88 per share Price / Book1.02Miscellaneous Outstanding Shares3,790,000Free Float3,527,000Market Cap$3.41 million OptionableNot Optionable Beta0.51 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:XRTX) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XORTX Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XORTX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.